XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated and Combined Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash $ 1,170,173 $ 3,353,732
Accounts receivable 999 999
Other receivable 302,500 302,500
Inventory 24,430 24,430
Prepaid expenses 508,818 206,784
Other current assets 607,376
Total Current Assets 2,614,296 3,888,445
Property and Equipment, net of depreciation 2,046,960 2,094,536
Patents, net of amortization 1,990,620 1,972,830
Total Assets 6,651,876 7,955,811
Current Liabilities:    
Accounts payable and accrued expenses 3,093,285 2,135,586
Income taxes payable 6,369
Excise tax payable 923,520 909,871
Derivative liabilities 12,855,200 25,272,650
Convertible notes 527,500
Short-term notes payable 1,875,290 1,917,962
Total Liabilities 18,835,168 30,857,811
Commitments and contingencies (Note 5)
Stockholders’ Equity (Deficit):    
Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value, 300,000,000 shares authorized, 2,716,706 and 2,633,956 issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 272 13,169
Additional paid-in capital 94,582,556 93,045,581
Stock subscription receivable (80,241) (80,241)
Accumulated deficit (106,685,879) (115,880,509)
Total Stockholders’ Equity (Deficit) (12,183,292) (22,902,000)
Total Liabilities and Stockholders’ Equity (Deficit) 6,651,876 7,955,811
Related Party    
Current Liabilities:    
Due to related party $ 87,873 $ 87,873